MicroPort NeuroTech Limited
MicroPort NeuroTech Limited (2172.HK) Stock Competitors & Peer Comparison
See (2172.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2172.HK | HK$10.81 | -1.46% | 6.2B | 30.03 | HK$0.36 | +1.48% |
| 2252.HK | HK$26.46 | -3.64% | 27.1B | -49.00 | -HK$0.54 | N/A |
| 0853.HK | HK$9.17 | -3.88% | 16.9B | -9.08 | -HK$1.01 | N/A |
| 1302.HK | HK$1.82 | +0.55% | 8B | 91.00 | HK$0.02 | N/A |
| 1858.HK | HK$13.07 | -5.50% | 7.8B | 27.23 | HK$0.48 | +2.17% |
| 2190.HK | HK$23.70 | -1.74% | 7.6B | 27.56 | HK$0.86 | +0.46% |
| 1789.HK | HK$6.43 | +1.42% | 7.2B | 18.91 | HK$0.34 | +1.12% |
| 1763.HK | HK$20.00 | -1.86% | 6.4B | 13.25 | HK$1.51 | +2.13% |
| 6606.HK | HK$14.14 | +0.00% | 6.3B | 58.92 | HK$0.24 | N/A |
| 9996.HK | HK$6.14 | -0.32% | 4.1B | -17.54 | -HK$0.35 | N/A |
Stock Comparison
2172.HK vs 2252.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2252.HK has a market cap of 27.1B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2252.HK trades at HK$26.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2252.HK's P/E ratio is -49.00. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2252.HK's ROE of -0.52%. Regarding short-term risk, 2172.HK is less volatile compared to 2252.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 2252.HK's competition here
2172.HK vs 0853.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 0853.HK has a market cap of 16.9B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 0853.HK trades at HK$9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 0853.HK's P/E ratio is -9.08. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 0853.HK's ROE of -0.27%. Regarding short-term risk, 2172.HK is less volatile compared to 0853.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 0853.HK's competition here
2172.HK vs 1302.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1302.HK has a market cap of 8B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1302.HK trades at HK$1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1302.HK's P/E ratio is 91.00. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1302.HK's ROE of +0.02%. Regarding short-term risk, 2172.HK is more volatile compared to 1302.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 1302.HK's competition here
2172.HK vs 1858.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1858.HK has a market cap of 7.8B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1858.HK trades at HK$13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1858.HK's P/E ratio is 27.23. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1858.HK's ROE of +0.09%. Regarding short-term risk, 2172.HK is less volatile compared to 1858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 1858.HK's competition here
2172.HK vs 2190.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2190.HK has a market cap of 7.6B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2190.HK trades at HK$23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2190.HK's P/E ratio is 27.56. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2190.HK's ROE of +0.08%. Regarding short-term risk, 2172.HK is more volatile compared to 2190.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 2190.HK's competition here
2172.HK vs 1789.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1789.HK has a market cap of 7.2B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1789.HK trades at HK$6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1789.HK's P/E ratio is 18.91. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1789.HK's ROE of +0.12%. Regarding short-term risk, 2172.HK is more volatile compared to 1789.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 1789.HK's competition here
2172.HK vs 1763.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1763.HK has a market cap of 6.4B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1763.HK trades at HK$20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1763.HK's P/E ratio is 13.25. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1763.HK's ROE of +0.06%. Regarding short-term risk, 2172.HK is more volatile compared to 1763.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 1763.HK's competition here
2172.HK vs 6606.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 6606.HK has a market cap of 6.3B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 6606.HK trades at HK$14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 6606.HK's P/E ratio is 58.92. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 6606.HK's ROE of -0.04%. Regarding short-term risk, 2172.HK is less volatile compared to 6606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 6606.HK's competition here
2172.HK vs 9996.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 9996.HK has a market cap of 4.1B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 9996.HK trades at HK$6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 9996.HK's P/E ratio is -17.54. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 2172.HK is more volatile compared to 9996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 9996.HK's competition here
2172.HK vs 6669.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 6669.HK has a market cap of 3.9B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 6669.HK trades at HK$13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 6669.HK's P/E ratio is 29.55. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 6669.HK's ROE of +0.07%. Regarding short-term risk, 2172.HK is more volatile compared to 6669.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 6669.HK's competition here
2172.HK vs 2235.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2235.HK has a market cap of 3.1B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2235.HK trades at HK$7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2235.HK's P/E ratio is -105.71. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2235.HK's ROE of -0.01%. Regarding short-term risk, 2172.HK is more volatile compared to 2235.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 2235.HK's competition here
2172.HK vs 6609.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 6609.HK has a market cap of 1.8B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 6609.HK trades at HK$48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 6609.HK's P/E ratio is 19.34. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 6609.HK's ROE of +0.04%. Regarding short-term risk, 2172.HK is more volatile compared to 6609.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 6609.HK's competition here
2172.HK vs 1696.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1696.HK has a market cap of 1.6B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1696.HK trades at HK$3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1696.HK's P/E ratio is 10.12. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1696.HK's ROE of +0.04%. Regarding short-term risk, 2172.HK is more volatile compared to 1696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 1696.HK's competition here
2172.HK vs 2160.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2160.HK has a market cap of 1.4B. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2160.HK trades at HK$2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2160.HK's P/E ratio is 145.00. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2160.HK's ROE of +0.00%. Regarding short-term risk, 2172.HK is less volatile compared to 2160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 2160.HK's competition here
2172.HK vs 2500.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2500.HK has a market cap of 959M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2500.HK trades at HK$2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2500.HK's P/E ratio is -2.09. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2500.HK's ROE of -0.30%. Regarding short-term risk, 2172.HK is less volatile compared to 2500.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 2500.HK's competition here
2172.HK vs 2407.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2407.HK has a market cap of 798.6M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2407.HK trades at HK$5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2407.HK's P/E ratio is 7.20. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2407.HK's ROE of +0.06%. Regarding short-term risk, 2172.HK is less volatile compared to 2407.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 2407.HK's competition here
2172.HK vs 2216.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2216.HK has a market cap of 721.2M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2216.HK trades at HK$1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2216.HK's P/E ratio is -4.42. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 2172.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 2216.HK's competition here
2172.HK vs 1612.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 1612.HK has a market cap of 597.3M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 1612.HK trades at HK$0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 1612.HK's P/E ratio is 5.41. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 1612.HK's ROE of +0.16%. Regarding short-term risk, 2172.HK is more volatile compared to 1612.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 1612.HK's competition here
2172.HK vs 2170.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2170.HK has a market cap of 547.1M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2170.HK trades at HK$2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2170.HK's P/E ratio is -1.96. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2170.HK's ROE of -0.17%. Regarding short-term risk, 2172.HK is more volatile compared to 2170.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 2170.HK's competition here
2172.HK vs 6118.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 6118.HK has a market cap of 410.1M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 6118.HK trades at HK$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 6118.HK's P/E ratio is 10.00. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 6118.HK's ROE of +0.04%. Regarding short-term risk, 2172.HK is less volatile compared to 6118.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2172.HK.Check 6118.HK's competition here
2172.HK vs 2297.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2297.HK has a market cap of 385.4M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2297.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2297.HK's P/E ratio is -2.75. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2297.HK's ROE of -0.26%. Regarding short-term risk, 2172.HK is more volatile compared to 2297.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 2297.HK's competition here
2172.HK vs 2393.HK Comparison April 2026
2172.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2172.HK stands at 6.2B. In comparison, 2393.HK has a market cap of 230.8M. Regarding current trading prices, 2172.HK is priced at HK$10.81, while 2393.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2172.HK currently has a P/E ratio of 30.03, whereas 2393.HK's P/E ratio is -1.24. In terms of profitability, 2172.HK's ROE is +0.10%, compared to 2393.HK's ROE of -0.35%. Regarding short-term risk, 2172.HK is more volatile compared to 2393.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2172.HK.Check 2393.HK's competition here